Fredun Pharmaceuticals539730Warrant news
Board approves allotment of 44,000 equity shares on conversion of 14,667 warrants
Board allotted 44,000 equity shares of face value Rs. 10/- each on conversion of 14,667 warrants.
By ScoutQuest · · 2 min read
25%Upfront share of warrant issue price
- Equity Shares Allotted
- 44,000 equity shares of face value Rs. 10/- each
- Warrants Converted
- 14,667 warrants
- Warrant Issue Price
- Rs. 1,250/- each, with 25% (Rs. 312.50/- per warrant) paid upfront
What the board approved
- Allotment of 44,000 fully paid-up equity shares of face value Rs. 10/- each.
- The shares were issued on conversion of 14,667 convertible warrants held by non-promoter allottees.
- The new shares will be issued in dematerialised form and will rank pari passu with the existing equity shares in all respects.
The original warrant terms
- Warrants were allotted on a preferential basis on 29th December, 2025, after shareholder approval at an Extra-Ordinary General Meeting held on 22nd October, 2025.
- Issue price was Rs. 1,250/- per warrant.
- Rs. 312.50/- per warrant, being 25% of the issue price, was payable upfront.
- The warrant holders have now paid the balance consideration and applied to exercise their conversion right.
The bonus issue adjustment
- The company made a 1:2 bonus issue, after which the entitlement attached to the outstanding warrants was adjusted as per the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
- Under the adjusted terms, each outstanding warrant is exercisable into three equity shares.
- That is how 14,667 warrants became 44,000 equity shares. The update notes the exercise price was revised accordingly as part of this adjustment.
Who received the shares
- 3 (Three) non-promoter investors: Divya Aggarwal, Indu Ramanlal Golecha and Sahil Dhir.
- Warrants allotted to them on 29th December, 2025 totalled 20,000, of which 14,667 have now been converted.
How to read this
- This is the final step of a fund-raising route that began with a preferential allotment of warrants. The money for the balance 75% of the warrant price has come in, and the company has issued shares in return.
- Because fresh shares are being issued, the total number of equity shares in the company goes up by 44,000. That means an existing shareholder's stake represents a marginally smaller percentage of the company than before. Warrants are usually counted in the diluted share count already, so the practical change for existing holders at this stage is limited.
- The shares carry the same rights as existing shares, including any dividend and voting rights declared on the equity shares.
Also from Fredun Pharmaceuticals
Allotment of 44,000 equity shares on conversion of 14,667 warrants
23 Oct 2026
Board Allots 1,82,400 Equity Shares on Conversion of 60,800 Warrants
5 Oct 2026
1,82,400 Equity Shares Allotted on Conversion of 60,800 Warrants
5 Oct 2026
More numbers
- Equity shares allotted on warrant conversion44,000
- Convertible warrants converted14,667
- Face value per equity shareRs. 10/-
- Warrants allotted on December 29, 2025 (total)20,000
- Issue price per warrantRs. 1,250/-
- Upfront amount paid per warrantRs. 312.50/-
- Upfront share of warrant issue price25%
- Number of investors allotted shares3 (Three)
Source: BSE · 23 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.